cp wire

CP Wire Articles

Eloxx Pharmaceuticals Seeks to Raise $50 Million in Public Offering

Eloxx Pharmaceuticals, Inc. (Nasdaq:ELOX) on 4/25/18 announced the pricing of an underwritten public offering of 5,130,000 shares of its common stock at a price to the public of $9.75 per share.... read more

Wed, 04/25/18 - 09:51 pm
Catabasis Pharmaceuticals' Edasalonexent Slowed Duchenne Muscular Dystrophy Disease Progression Through One Year of Treatment

Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, reported on 4/25/18 new positive magnetic resonance efficacy results showing slowed disease progression... read more

Wed, 04/25/18 - 07:39 pm
Canadian STEMCELL Technologies Receives $45 Million Government Funding for Advanced Manufacturing Facility

STEMCELL Technologies  announced on 4/25/18 a $45 million joint funding agreement between the Governments of Canada and British Columbia to help the company build a state-of-the-art advanced... read more

Wed, 04/25/18 - 04:47 pm
Is Vaxart One to Watch...Maybe?

Vaxart is a clinical stage biopharmaceutical company that seems to hold a great deal of promise. They are developing several oral tablet vaccines with the most promising being a vaccine for... read more

Wed, 04/25/18 - 01:59 pm
First Patient Dosed in Avexis' Phase 3 Trial of AVXS-101 in Pre-Symptomatic Spinal Muscular Atrophy
  • AVXS-101, has potential to be first-ever one-time gene replacement therapy for spinal muscular atrophy (SMA), a disease which results in early death or lifelong disability with considerable... read more
Wed, 04/25/18 - 09:46 am

Pages